Gene · 368
Papers1,933
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 1,933
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Vitamin D and Calcium Supplementation Accelerate Vascular Calcification in a Model of Pseudoxanthoma Elasticum. | Int J Mol Sci | 2022 | 35216422 | PubTator, text mining | PubMed |
| Zebrafish as a Model to Study Vascular Elastic Fibers and Associated Pathologies. | Int J Mol Sci | 2022 | 35216218 | PubTator, text mining | PubMed |
| Activation of ABCC Genes by Cisplatin Depends on the CoREST Occurrence at Their Promoters in A549 and MDA-MB-231 Cell Lines. | Cancers (Basel) | 2022 | 35205642 | PubTator, text mining | PubMed |
| Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System. | Gels | 2022 | 35200463 | PubTator, text mining | PubMed |
| Genetic associations of protein-coding variants in human disease. | Nature | 2022 | 35197637 | PubTator, text mining | PubMed |
| Effects of gestational exposure to bisphenol A on the hepatic transcriptome and lipidome of rat dams: Intergenerational comparison of effects in the offspring. | Sci Total Environ | 2022 | 35192832 | PubTator, text mining | PubMed |
| Abcc6 Null Mice-a Model for Mineralization Disorder PXE Shows Vertebral Osteopenia Without Enhanced Intervertebral Disc Calcification With Aging. | Front Cell Dev Biol | 2022 | 35186933 | PubTator, text mining | PubMed |
| Inorganic Pyrophosphate Deficiency Syndromes and Potential Treatments for Pathologic Tissue Calcification. | Am J Pathol | 2022 | 35182493 | PubTator, text mining | PubMed |
| Minocycline Counteracts Ectopic Calcification in a Murine Model of Pseudoxanthoma Elasticum: A Proof-of-Concept Study. | Int J Mol Sci | 2022 | 35163765 | PubTator, text mining | PubMed |
| Control of Gene Expression via the Yeast CWI Pathway. | Int J Mol Sci | 2022 | 35163713 | PubTator, text mining | PubMed |
| Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC. | Int J Mol Sci | 2022 | 35163586 | PubTator, text mining | PubMed |
| The Genetic Basis of Strokes in Pediatric Populations and Insight into New Therapeutic Options. | Int J Mol Sci | 2022 | 35163523 | PubTator, text mining | PubMed |
| Drug Disposition Protein Quantification in Matched Human Jejunum and Liver From Donors With Obesity. | Clin Pharmacol Ther | 2022 | 35158408 | PubTator, text mining | PubMed |
| The Mineralization Regulator ANKH Mediates Cellular Efflux of ATP, Not Pyrophosphate. | J Bone Miner Res | 2022 | 35147247 | PubTator, text mining | PubMed |
| Inhibition of the DNA Damage Response Attenuates Ectopic Calcification in Pseudoxanthoma Elasticum. | J Invest Dermatol | 2022 | 35143822 | PubTator, text mining | PubMed |
| CTCFL regulates the PI3K-Akt pathway and it is a target for personalized ovarian cancer therapy. | NPJ Syst Biol Appl | 2022 | 35132075 | PubTator, text mining | PubMed |
| Transport and metabolism of tyrosine kinase inhibitors associated with chronic myeloid leukemia therapy: a review. | Mol Cell Biochem | 2022 | 35129779 | PubTator, text mining | PubMed |
| The CanPain SCI clinical practice guidelines for rehabilitation management of neuropathic pain after spinal cord injury: 2021 update. | Spinal Cord | 2022 | 35124700 | PubTator, text mining | PubMed |
| Osteocalcin-expressing endothelial progenitor cells and serum osteocalcin forms are independent biomarkers of coronary atherosclerotic disease severity in male and female patients. | J Endocrinol Invest | 2022 | 35089541 | PubTator, text mining | PubMed |
| An evaluation of pipelines for DNA variant detection can guide a reanalysis protocol to increase the diagnostic ratio of genetic diseases. | NPJ Genom Med | 2022 | 35087072 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/368/papers?page=23